top of page


In the realm of infectious diseases, timely and accurate diagnosis is paramount for effective treatment. Fungal infections, often

subtle and challenging, have historically been diagnosed through conventional methods such as culture-based techniques.


The landscape of diagnostic methodologies is rapidly evolving, and molecular testing is emerging as a game-changer in the identification and management of fungal pathogens. Below we will explore the numerous advantages of molecular fungal testing over traditional methods.



Quantifying the Threat: Fungal load assessment molecular testing goes beyond simple detection; it allows for the quantification of fungal load in a given sample. This quantitative aspect aids clinicians in assessing the severity of the infection, monitoring treatment efficacy, and adjusting therapeutic strategies accordingly.


Resistance at the Genetic Level: The rise of antifungal resistance is a growing concern. Molecular testing can be tailored to detect specific genetic markers associated with resistance, enabling clinicians to make informed decisions about the most effective antifungal treatments.


Detects Mixed Infection: In some cases, fungal infections may involve multiple species simultaneously. Molecular testing’s ability to identify multiple pathogens in a single sample ensures a more comprehensive understanding of the infection, guiding clinicians toward targeted and effective treatments.


Early Intervention for the Vulnerable: Immunocompromised individuals, such as those undergoing chemotherapy or organ transplantation, are at heightened risk of fungal infections. Molecular testing’s high sensitivity allows for early detection, a crucial factor in preventing the progression of infections in this vulnerable population.

Speed of Diagnosis: Molecular testing, particularly Polymerase Chain Reaction (PCR), has revolutionized the diagnostic timeline. With the ability to amplify and detect specific DNA sequences, molecular tests provide results in a matter of hours, allowing for prompt initiation of targeted therapy and reducing the risk of complications.


Precise Identification: One of the primary limitations of conventional methods is the challenge to accurately identify a fungal species. Molecular testing offers precise identification through the detection of specific genetic markers. Knowing the exact species is crucial for tailoring treatment plans, as different fungi may respond differently to antifungal medications.


Sensitivity Unleashed: Fungal infections, especially in their

early stages, may present with low pathogen concentrations. Molecular testing, with its high sensitivity, can identify even minute amounts of fungal DNA. This capability is particularly valuable for early diagnosis and intervention.


Detects Non Cultural Fungi: Certain fungi pose a challenge

in the laboratory due to slow growth or an inability to culture. Molecular testing overcomes this by directly detecting the genetic material of non-culturable or slow-growing fungi, providing a more comprehensive diagnostic approach.

15 Pathogens Tested


Aspergillus terreus

Candida albicans

Candida Auris

Candida dubliniensis

Fusarium solani


Microsporum audouinii

Trichophyton interdigitale

Trichophyton rubrum

Candida glabrata

Candida lusitaniae

Candida parapsilosis

Candida tropicalis

Epidermophyton floccosum


Phi Life Sciences Molecular Fungal Testing Includes:


• Collection kit including collection tube and biohazard bag.

• Comprehensive collection instructions.

• Return shipping or sample pick up.

• On line result reporting 24-48 hours after sample receipt.

• Easy to interpret patient-focused report which allows providers

to effectively address pathogens while maintaining responsible antibiotic stewardship.

bottom of page